Table 3.
IC50 (µg/mL) of Nos@AgNPs, Ch@AgNPs, 5-FU, and Doxo Against T47D, MDA-MB231, MCF-7, MCF-7ADR, Sw480, A549, HFs, and Vero Cells
| Cells | Nos@AgNPs | Ch@AgNPs | 5-FU | Doxorubicin |
|---|---|---|---|---|
| T47D | 50.02 | 657 | 12.7 | < 1000 |
| MDA-MB231 | 118.1 | 256.9 | 442.7 | 125 |
| MCF-7 | 271.9 | 31.18 | 56.48 | 2.394 |
| MCF-7ADR | 50.41 | 32.919 | < 1000 | 1000 |
| Sw480 | 81.42 | 28.28 | 49.18 | 1000 |
| A549 | 21.56 | 573.4 | 29.85 | 6.447 |
| HFs | 18.78 | 54.06 | 32.43 | 415 |
| Vero | 5.758 | 18.51 | 33.12 | < 1000 |